BRIEF published on 04/11/2025 at 20:05, 9 months 24 days ago Oxurion Publie son Rapport Annuel 2024 et Convoque son Assemblée Générale Déclarations Prospectives Rapport Annuel 2024 Oxurion NV Thérapies Ophtalmologiques Assemblées Actionnaires
BRIEF published on 04/11/2025 at 20:05, 9 months 24 days ago Oxurion Publishes its 2024 Annual Report and Convenes its General Meeting Forward-looking Statements Annual Report 2024 Ophthalmic Therapies Shareholders' Meetings Oxurion NV
PRESS RELEASE published on 04/11/2025 at 20:05, 9 months 24 days ago Publication Annual Report - Annual Shareholders' Meeting Oxurion NV releases its annual report for the financial year 2024 and convenes its Annual Shareholders' Meeting in Leuven, Belgium. Developing ophthalmic therapies for retinal disease Shareholders' Meeting Annual Report Ophthalmic Therapies Oxurion NV Retinal Disease
PRESS RELEASE published on 04/11/2025 at 20:00, 9 months 24 days ago Publicatie jaarverslag - Jaarlijkse Algemene Vergadering Oxurion NV publice son rapport annuel 2024, convoque son assemblée annuelle d'actionnaires et se concentre sur les thérapies ophtalmologiques Rapport Annuel 2024 Oxurion NV Assemblée Annuelle Thérapies Ophtalmologiques Biofarmaceutique
BRIEF published on 04/04/2025 at 14:05, 10 months 1 day ago Report de l'Assemblée Générale d'Oxurion Assemblée Générale Biopharmaceutique Report Oxurion Thérapies Ophtalmologiques
BRIEF published on 04/04/2025 at 14:05, 10 months 1 day ago Oxurion General Meeting Postponed General Meeting Biopharmaceuticals Report Ophthalmic Therapies Oxurion
PRESS RELEASE published on 04/04/2025 at 14:00, 10 months 1 day ago Uitstel Gewone Algemene Vergadering Oxurion NV annonce le report de son Assemblée Générale des Actionnaires au 13 mai 2025 en raison de l'indisponibilité de ses états financiers Assemblée Générale États Financiers Report Risques Oxurion NV
PRESS RELEASE published on 04/04/2025 at 14:00, 10 months 1 day ago Postponement Annual Shareholders Meeting Oxurion NV postponed its Annual Shareholders Meeting to May 13, 2025, due to pending annual accounts. The biopharmaceutical company, focused on ophthalmic therapies, is based in Leuven, Belgium Biopharmaceutical Annual Shareholders Meeting Postponed Ophthalmic Therapies Oxurion NV
BRIEF published on 04/02/2025 at 18:05, 10 months 3 days ago Oxurion reçoit une notification de transparence de Atlas Special Opportunities II LLC Actions Transparence Atlas Special Opportunities Oxurion Biopharmacie
BRIEF published on 04/02/2025 at 18:05, 10 months 3 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Oxurion Biopharmacy
Published on 02/06/2026 at 00:57, 23 minutes ago Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 1 hour 20 minutes ago LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 2 hours 5 minutes ago Amarc Further Expands Its Toodoggone Technical Team
Published on 02/05/2026 at 23:00, 2 hours 20 minutes ago Grounded People Announces Non-Brokered Private Placement and Strategic Review
Published on 02/05/2026 at 21:00, 4 hours 20 minutes ago Kidoz Welcomes CloudX Innovation Driving Fairer Mobile Advertising Auctions
Published on 02/05/2026 at 19:27, 5 hours 52 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 6 hours 34 minutes ago EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 7 hours 11 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 7 hours 25 minutes ago Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 7 hours 40 minutes ago BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 19:15, 6 hours 5 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 6 hours 5 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 6 hours 5 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
